These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 152336)

  • 21. Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: host response but not bacterial species is the determinant factor of the disease.
    Sugisaki H; Yamanaka K; Kakeda M; Kitagawa H; Tanaka K; Watanabe K; Gabazza EC; Kurokawa I; Mizutani H
    J Dermatol Sci; 2009 Jul; 55(1):47-52. PubMed ID: 19375895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IgG subclasses specific to Staphylococcus epidermidis and Propionibacterium acnes in patients with acne vulgaris.
    Ashbee HR; Muir SR; Cunliffe WJ; Ingham E
    Br J Dermatol; 1997 May; 136(5):730-3. PubMed ID: 9205507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Propionibacterium acnes and inflammation in acne; P. acnes has T-cell mitogenic activity.
    Jappe U; Ingham E; Henwood J; Holland KT
    Br J Dermatol; 2002 Feb; 146(2):202-9. PubMed ID: 11903228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Leukocyte migration inhibition factor in acne vulgaris].
    Vignale RA; Lasalvia E; Paciel J
    Med Cutan Ibero Lat Am; 1980; 8(4-6):101-3. PubMed ID: 6456387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Propionibacterium acnes-reactive T helper-1 cells in the skin of patients with acne vulgaris.
    Mouser PE; Baker BS; Seaton ED; Chu AC
    J Invest Dermatol; 2003 Nov; 121(5):1226-8. PubMed ID: 14708633
    [No Abstract]   [Full Text] [Related]  

  • 26. [Blastogenic response in vitro of lymphocyte acne vulgaris].
    Assandri J; Vignale RA; Lasalvia E; Paciel J
    Med Cutan Ibero Lat Am; 1977; 5(2):115-9. PubMed ID: 147371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acne: inflammation.
    Farrar MD; Ingham E
    Clin Dermatol; 2004; 22(5):380-4. PubMed ID: 15556722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of innate immunity in the pathogenesis of acne.
    Koreck A; Pivarcsi A; Dobozy A; Kemény L
    Dermatology; 2003; 206(2):96-105. PubMed ID: 12592074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemotactic efficiency of various chemoattractants for polymorphonuclear leukocytes in inflammatory acne vulgaris.
    Knop J; Bossecker T; Kövary PM
    Arch Dermatol Res; 1982; 274(3-4):267-75. PubMed ID: 6219635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acne-like chronic inflammatory activity of Propionibacterium acnes preparations in an animal model: correlation with ability to stimulate the reticuloendothelial system.
    De Young LM; Spires DA; Ballaron SJ; Cummins CS; Young JM; Allison AC
    J Invest Dermatol; 1985 Sep; 85(3):255-8. PubMed ID: 3161957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acne from an immunological perspective.
    Puhvel SM
    Cutis; 1976 Mar; 17(3):502-6. PubMed ID: 138543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The immunobiology of acne. A polyvalent proprionibacteria vaccine.
    Goldman L; Michael JG; Riebel S
    Cutis; 1979 Feb; 23(2):181-4. PubMed ID: 154393
    [No Abstract]   [Full Text] [Related]  

  • 33. Lymphocyte transformation in subjects with nodulo cystic acne.
    Puhvel SM; Amirian D; Weintraub J; Reisner RM
    Br J Dermatol; 1977 Aug; 97(2):205-11. PubMed ID: 143951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of a chemoattractive proinflammatory cytokine response after stimulation of keratinocytes with Propionibacterium acnes and coproporphyrin III.
    Schaller M; Loewenstein M; Borelli C; Jacob K; Vogeser M; Burgdorf WH; Plewig G
    Br J Dermatol; 2005 Jul; 153(1):66-71. PubMed ID: 16029328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enzyme production of propionibacteria from patients with acne vulgaris and healthy persons.
    Höffler U; Gehse M; Gloor M; Pulverer G
    Acta Derm Venereol; 1985; 65(5):428-32. PubMed ID: 2416168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topically applied antibiotics in acne vulgaris: clinical response and suppression of Corynebacterium acnes in open comedones.
    Resh W; Stoughton RB
    Arch Dermatol; 1976 Feb; 112(2):182-4. PubMed ID: 134675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review of the innate immune response in acne vulgaris: activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses.
    Kim J
    Dermatology; 2005; 211(3):193-8. PubMed ID: 16205063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of distribution patterns of Propionibacterium acnes phylotypes and Peptostreptococcus species from acne lesions.
    Kwon HH; Yoon JY; Park SY; Suh DH
    Br J Dermatol; 2013 Nov; 169(5):1152-5. PubMed ID: 23795647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammatory acne represents hypersensitivity to Propionibacterium acnes.
    Webster GF
    Dermatology; 1998; 196(1):80-1. PubMed ID: 9557234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The microbial content and complement C3 cleaving capacity of comedones in acne vulgaris.
    Leeming JP; Ingham E; Cunliffe WJ
    Acta Derm Venereol; 1988; 68(6):468-73. PubMed ID: 2467483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.